Listed

PMV Pharmaceuticals, Inc.

PMVPNasdaqCIK 1699382HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$18.9m, Q2 FY2026
Net income−$18.1m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m13.6Research and development, Q3 FY2023, three months to 2023-09-30$13.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-122817.Report this figure13.4Research and development, Q4 FY2023, three months to 2023-12-31$13.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figure13.2Research and development, Q1 FY2024, three months to 2024-03-31$13.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-09, accession 0000950170-25-067513.Report this figure14.6Research and development, Q2 FY2024, three months to 2024-06-30$14.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104588.Report this figure16.9Research and development, Q3 FY2024, three months to 2024-09-30$16.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure13.8Research and development, Q4 FY2024, three months to 2024-12-31$13.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figure17.4Research and development, Q1 FY2025, three months to 2025-03-31$17.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure18.4Research and development, Q2 FY2025, three months to 2025-06-30$18.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure18.2Research and development, Q3 FY2025, three months to 2025-09-30$18.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure15.8Research and development, Q4 FY2025, three months to 2025-12-31$15.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figure15.3Research and development, Q1 FY2026, three months to 2026-03-31$15.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure14.7Research and development, Q2 FY2026, three months to 2026-06-30$14.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure
Operating income$m(19.6)Operating income, Q3 FY2023, three months to 2023-09-30−$19.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122817.Report this figure(18.9)Operating income, Q4 FY2023, three months to 2023-12-31−$18.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figure(18.2)Operating income, Q1 FY2024, three months to 2024-03-31−$18.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-09, accession 0000950170-25-067513.Report this figure(20.2)Operating income, Q2 FY2024, three months to 2024-06-30−$20.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-104588.Report this figure(21.9)Operating income, Q3 FY2024, three months to 2024-09-30−$21.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure(25.2)Operating income, Q4 FY2024, three months to 2024-12-31−$25.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figure(21.6)Operating income, Q1 FY2025, three months to 2025-03-31−$21.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure(22.9)Operating income, Q2 FY2025, three months to 2025-06-30−$22.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure(22.5)Operating income, Q3 FY2025, three months to 2025-09-30−$22.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure(19.2)Operating income, Q4 FY2025, three months to 2025-12-31−$19.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figure(19.0)Operating income, Q1 FY2026, three months to 2026-03-31−$19.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure(18.9)Operating income, Q2 FY2026, three months to 2026-06-30−$18.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure
Income tax$m(0.0)Income tax, Q3 FY2023, three months to 2023-09-30−$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0000950170-24-122817. Derived: 9-month figure less the 6-month figure.Report this figure(0.0)Income tax, Q4 FY2023, three months to 2023-12-31−$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figurenot reported(16.2)Income tax, Q2 FY2024, three months to 2024-06-30−$16.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-104588.Report this figure0.1Income tax, Q3 FY2024, three months to 2024-09-30$74.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figure(2.2)Income tax, Q1 FY2025, three months to 2025-03-31−$2.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$5.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure(0.0)Income tax, Q3 FY2025, three months to 2025-09-30−$6.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$26.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Income tax, Q2 FY2026, three months to 2026-06-30$3.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure
Net income$m(16.6)Net income, Q3 FY2023, three months to 2023-09-30−$16.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122817.Report this figure(15.8)Net income, Q4 FY2023, three months to 2023-12-31−$15.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figure(15.3)Net income, Q1 FY2024, three months to 2024-03-31−$15.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure(1.2)Net income, Q2 FY2024, three months to 2024-06-30−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure(19.2)Net income, Q3 FY2024, three months to 2024-09-30−$19.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure(23.0)Net income, Q4 FY2024, three months to 2024-12-31−$23.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figure(17.4)Net income, Q1 FY2025, three months to 2025-03-31−$17.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure(21.2)Net income, Q2 FY2025, three months to 2025-06-30−$21.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure(21.1)Net income, Q3 FY2025, three months to 2025-09-30−$21.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure(18.0)Net income, Q4 FY2025, three months to 2025-12-31−$18.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figure(18.0)Net income, Q1 FY2026, three months to 2026-03-31−$18.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure(18.1)Net income, Q2 FY2026, three months to 2026-06-30−$18.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure
Diluted EPS$ per share(0.34)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-122817.Report this figurenot reported(0.30)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-09, accession 0000950170-25-067513.Report this figure(0.02)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-104588.Report this figure(0.37)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figurenot reported(0.34)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure(0.41)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure(0.40)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figurenot reported(0.34)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure(0.34)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure
Basic EPS$ per share(0.34)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-122817.Report this figurenot reported(0.30)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-09, accession 0000950170-25-067513.Report this figure(0.02)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-104588.Report this figure(0.37)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figurenot reported(0.34)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure(0.41)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure(0.40)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figurenot reported(0.34)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure(0.34)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure

Balance sheet

Cash and equivalents$12.5m, Q2 FY2026
Shareholders' equity$71.5m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m52.1Cash and equivalents, Q3 FY2023, at 2023-09-30$52.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0000950170-23-061551.Report this figure37.7Cash and equivalents, FY2023, at 2023-12-31$37.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-03, accession 0000950170-25-030414.Report this figure47.7Cash and equivalents, Q1 FY2024, at 2024-03-31$47.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0000950170-24-056295.Report this figure48.5Cash and equivalents, Q2 FY2024, at 2024-06-30$48.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-093343.Report this figure48.8Cash and equivalents, Q3 FY2024, at 2024-09-30$48.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-122817.Report this figure40.9Cash and equivalents, FY2024, at 2024-12-31$40.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-06, accession 0001193125-26-095014.Report this figure51.3Cash and equivalents, Q1 FY2025, at 2025-03-31$51.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-09, accession 0000950170-25-067513.Report this figure44.1Cash and equivalents, Q2 FY2025, at 2025-06-30$44.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-104588.Report this figure36.3Cash and equivalents, Q3 FY2025, at 2025-09-30$36.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure38.0Cash and equivalents, FY2025, at 2025-12-31$38.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure39.1Cash and equivalents, Q1 FY2026, at 2026-03-31$39.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure12.5Cash and equivalents, Q2 FY2026, at 2026-06-30$12.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure
Current assets$m205Current assets, Q3 FY2023, at 2023-09-30$205.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-061551.Report this figure207Current assets, FY2023, at 2023-12-31$207.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-03, accession 0000950170-25-030414.Report this figure202Current assets, Q1 FY2024, at 2024-03-31$202.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056295.Report this figure219Current assets, Q2 FY2024, at 2024-06-30$218.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093343.Report this figure190Current assets, Q3 FY2024, at 2024-09-30$189.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122817.Report this figure176Current assets, FY2024, at 2024-12-31$175.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-06, accession 0001193125-26-095014.Report this figure163Current assets, Q1 FY2025, at 2025-03-31$163.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-09, accession 0000950170-25-067513.Report this figure145Current assets, Q2 FY2025, at 2025-06-30$145.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104588.Report this figure132Current assets, Q3 FY2025, at 2025-09-30$132.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure115Current assets, FY2025, at 2025-12-31$115.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure95.8Current assets, Q1 FY2026, at 2026-03-31$95.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure81.4Current assets, Q2 FY2026, at 2026-06-30$81.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure
Total assets$m261Total assets, Q3 FY2023, at 2023-09-30$261.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-061551.Report this figure252Total assets, FY2023, at 2023-12-31$252.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-03, accession 0000950170-25-030414.Report this figure237Total assets, Q1 FY2024, at 2024-03-31$236.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-056295.Report this figure238Total assets, Q2 FY2024, at 2024-06-30$237.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093343.Report this figure223Total assets, Q3 FY2024, at 2024-09-30$223.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-122817.Report this figure191Total assets, FY2024, at 2024-12-31$191.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-06, accession 0001193125-26-095014.Report this figure171Total assets, Q1 FY2025, at 2025-03-31$170.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-09, accession 0000950170-25-067513.Report this figure153Total assets, Q2 FY2025, at 2025-06-30$152.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-104588.Report this figure134Total assets, Q3 FY2025, at 2025-09-30$133.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure117Total assets, FY2025, at 2025-12-31$116.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure96.6Total assets, Q1 FY2026, at 2026-03-31$96.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure82.1Total assets, Q2 FY2026, at 2026-06-30$82.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure
Current liabilities$m10.7Current liabilities, Q3 FY2023, at 2023-09-30$10.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-061551.Report this figure14.0Current liabilities, FY2023, at 2023-12-31$14.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-03, accession 0000950170-25-030414.Report this figure12.1Current liabilities, Q1 FY2024, at 2024-03-31$12.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056295.Report this figure11.4Current liabilities, Q2 FY2024, at 2024-06-30$11.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093343.Report this figure13.6Current liabilities, Q3 FY2024, at 2024-09-30$13.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122817.Report this figure14.4Current liabilities, FY2024, at 2024-12-31$14.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-06, accession 0001193125-26-095014.Report this figure9.8Current liabilities, Q1 FY2025, at 2025-03-31$9.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-09, accession 0000950170-25-067513.Report this figure11.6Current liabilities, Q2 FY2025, at 2025-06-30$11.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104588.Report this figure12.3Current liabilities, Q3 FY2025, at 2025-09-30$12.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure11.4Current liabilities, FY2025, at 2025-12-31$11.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure8.6Current liabilities, Q1 FY2026, at 2026-03-31$8.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure10.6Current liabilities, Q2 FY2026, at 2026-06-30$10.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure
Total liabilities$m23.4Total liabilities, Q3 FY2023, at 2023-09-30$23.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-061551.Report this figure26.5Total liabilities, FY2023, at 2023-12-31$26.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-03, accession 0000950170-25-030414.Report this figure24.2Total liabilities, Q1 FY2024, at 2024-03-31$24.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-056295.Report this figure23.2Total liabilities, Q2 FY2024, at 2024-06-30$23.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093343.Report this figure25.6Total liabilities, Q3 FY2024, at 2024-09-30$25.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-122817.Report this figure15.2Total liabilities, FY2024, at 2024-12-31$15.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-06, accession 0001193125-26-095014.Report this figure10.5Total liabilities, Q1 FY2025, at 2025-03-31$10.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-09, accession 0000950170-25-067513.Report this figure12.3Total liabilities, Q2 FY2025, at 2025-06-30$12.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-104588.Report this figure12.8Total liabilities, Q3 FY2025, at 2025-09-30$12.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure11.9Total liabilities, FY2025, at 2025-12-31$11.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure8.6Total liabilities, Q1 FY2026, at 2026-03-31$8.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure10.6Total liabilities, Q2 FY2026, at 2026-06-30$10.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure
Shareholders' equity$m238Shareholders' equity, Q3 FY2023, at 2023-09-30$237.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-122817.Report this figure226Shareholders' equity, FY2023, at 2023-12-31$225.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-06, accession 0001193125-26-095014.Report this figure213Shareholders' equity, Q1 FY2024, at 2024-03-31$212.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure214Shareholders' equity, Q2 FY2024, at 2024-06-30$214.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure198Shareholders' equity, Q3 FY2024, at 2024-09-30$197.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure176Shareholders' equity, FY2024, at 2024-12-31$176.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure160Shareholders' equity, Q1 FY2025, at 2025-03-31$160.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure141Shareholders' equity, Q2 FY2025, at 2025-06-30$140.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure121Shareholders' equity, Q3 FY2025, at 2025-09-30$121.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure105Shareholders' equity, FY2025, at 2025-12-31$104.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure88.0Shareholders' equity, Q1 FY2026, at 2026-03-31$88.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure71.5Shareholders' equity, Q2 FY2026, at 2026-06-30$71.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure

Cash flow

Operating cash flow−$14.6m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(15.7)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$15.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-122817. Derived: 9-month figure less the 6-month figure.Report this figure(12.1)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$12.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figure(16.2)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$16.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-09, accession 0000950170-25-067513.Report this figure(1.6)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-104588. Derived: 6-month figure less the 3-month figure.Report this figure(16.8)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$16.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-276003. Derived: 9-month figure less the 6-month figure.Report this figure(16.7)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$16.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figure(18.3)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$18.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure(18.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$18.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001193125-26-350448. Derived: 6-month figure less the 3-month figure.Report this figure(19.8)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$19.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-276003. Derived: 9-month figure less the 6-month figure.Report this figure(17.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$17.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figure(19.7)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$19.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure(14.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$14.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001193125-26-350448. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$44.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-122817. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2023, three months to 2023-12-31$197.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figure0.6Capital expenditure, Q1 FY2024, three months to 2024-03-31$594.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-09, accession 0000950170-25-067513.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$4.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-104588. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-276003. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$56.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$4.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$11.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001193125-26-350448. Derived: 6-month figure less the 3-month figure.Report this figure(0.0)Capital expenditure, Q3 FY2025, three months to 2025-09-30−$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-276003. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$15.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-06, accession 0001193125-26-095014. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001193125-26-350448. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)53.39m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q3 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares45.6Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3045,622,957 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-061551.Report this figure45.8Diluted shares (weighted), Q3 FY2023, three months to 2023-03-3145,773,357 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-056295.Report this figure45.8Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3045,813,132 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-093343.Report this figure49.0Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3049,047,296 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-122817.Report this figure51.4Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3151,445,862 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-09, accession 0000950170-25-067513.Report this figure51.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3051,478,751 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-104588.Report this figure51.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3051,574,027 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure52.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3151,952,062 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure52.0Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3052,010,827 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure53.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3052,993,238 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-276003.Report this figure53.3Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3153,331,766 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-218227.Report this figure53.4Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3053,386,909 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure

Shares outstanding: 53.46mShares outstanding, period not labelled, at 2026-08-1453,458,058 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-14, accession 0001193125-26-350448.Report this figure at Aug 14, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.